VLNS

15-12G - Valens Company, Inc. (0001859902) (Filer)

F-10POS - Valens Company, Inc. (0001859902) (Filer)

6-K - Valens Company, Inc. (0001859902) (Filer)

SNDL Inc. (NASDAQ:SNDL) completed the previously disclosed acquisition of all of the issued and outstanding common shares of The Valens Company Inc. (NASDAQ:VLNS) (TSX:VLNS), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act, for total consideration of approximately CA$138 million ($103 million) consisting of common shares of SNDL and assumption of Valens' CA$60 million non-revolving term loan facility. With approximately CA$262.5 million in net cash and no debt, SNDL will continue to have one of the strongest balance sheets in the North American cannabis industry. The combined company will operate as SNDL Inc.,

25-NSE - Valens Company, Inc. (0001859902) (Subject)

Creates a low-cost vertically integrated Canadian company generating over a billion dollars in annualized pro forma revenue1 CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for tota

6-K - Valens Company, Inc. (0001859902) (Filer)

The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS), announced that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement with SNDL Inc. (NASDAQ:SNDL) under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the arrangement, Valens' shareholders will receive, for each common share of Valens, 0.3334 of a common share of SNDL. Based on the closing price of the SNDL shares on the Nasdaq Capital Market as at August 19, 2022, the consideration represents an implied value of CA$1.26 per Valens S

 The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement, Valens' shareholders will receive, for each common share of Valens (each, a "Valens Share"), 0.3334 of a common share of SNDL (the "Offer Exchange Ratio")

KELOWNA, BC, Jan. 3, 2023 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement

The Valens Company Inc. (NASDAQ:VLNS) (TSX:VLNS), received an extension of 180 calendar days from the Nasdaq Stock Market LLC to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market, following the expiration of the initial 180 calendar days period to regain compliance on December 12, 2022. The Nasdaq determination is based on the company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the bid price requirement, and the company's written

6-K - Valens Company, Inc. (0001859902) (Filer)

KELOWNA, BC, Dec. 13, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on December 12, 2022. The Nasdaq determination is based on the Company meeting the continued listing requirement for mar

6-K - Valens Company, Inc. (0001859902) (Filer)

The Valens Company Inc. (NASDAQ:VLNS) (TSX:VLNS) announced that its shareholders have voted in favor of the resolution approving the plan of arrangement pursuant to which SNDL Inc. (NASDAQ:SNDL) will acquire all of the issued and outstanding common shares of Valens on the basis of 0.3334 of a SNDL common share for each outstanding Valens common share, on and subject to the terms of the arrangement agreement dated August 22, 2022 to which Valens and SNDL are parties. Over 96% of votes cast at the company's special meeting of shareholders held on November 29, 2022 were in favor of the resolution. "With this announcement, we are one step closer to combining two best-in-class cannabis companies

The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") is pleased to announce that its shareholders have voted in favour of the resolution (the "Resolution") approving the plan of arrangement pursuant to which SNDL Inc. ("SNDL") will acquire all of the issued and outstanding common shares of Valens on the basis of 0.3334 of a SNDL common share for each outstanding Valens common share (the "Arrangement"), on and subject to the terms of the arrangement agreement dated August 22, 2022 to which Valens and SNDL are parties (the "Agreement"). Over 96% of votes cast at the Company's special meeting of shareholders held on November 29, 2022 were in favour of the Resolution.

ISS highlights that "the arrangement is expected to produce upwards of $15 million of additional EBITDA on an annual run-rate basis through synergies and other strategic initiatives" and that "shareholder approval of arrangement resolution is warranted" Glass Lewis cites the strategic rationale as one of the keys reasons for recommending shareholders vote FOR the Arrangement Shareholders are encouraged to vote well in advance of the proxy deadline of November 25, 2022 at 10:00 a.m. (Toronto time) Shareholders who have questions or need assistance in voting should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 (North American Toll Free) or 1-416-304-0211 (Outside North Amer

SNDL Inc. (NASDAQ:SNDL) shares are trading 8.85% higher at $2.83 per share during Monday’s pre-market session. The company released its financial results for the third quarter this morning, revealing record net revenue of CA$230.5 million ($173.3 million), compared to CA$223.7 million in the second quarter of 2022 and CA$14.4 million in the third quarter of 2021, representing a 3% increase sequentially and 1,501% increase year-over-year. The results for the third quarter of 2021 do not include the subsequent acquisition of Alcanna Inc., which closed on March 31, 2022. Q3 2022 Financial Highlights Net loss was CA$98.8 million, compared to net income of CA$16.7 million for three months e

The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) has received a sales license amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area to sell micro processed cannabis products directly to provincial distributors. Prior to this announcement, Valens leveraged its British Columbia sales license to sell into the provincial distributors which created additional cost and complexity in our supply chain. With this amendment now in place, products produced at the companies GTA Facility will benefit from a streamlined, direct route to market that the company believes will increase margins and overall company efficiencies. "Since the opening of our facil

KELOWNA, BC, Nov. 2, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors. Prior to this announcement, Valens leveraged its British Columbia sales licence to sell into the provincial distributors which created additional cost and complexity in our supply chain. With this amendment now in place, products produced a

Sales growth in Canada appears to be stagnating for the cannabis sector. Recently, Statistics Canada released August retail sales reporting that cannabis sales increased from July by 0.2% to CA$393.7 million ($288 million). However, in August, sales increased 13.0% from one year earlier, down from July's 17.2% growth rate. What Does Data Say? An Expert's Analysis According to Cantor Fitzgerald's Pablo Zuanic, the Canadian adult-use cannabis market “continued to decelerate in the third Quarter of 2022 when taking Year-Over-Year (YoY) trends, with Quarter on Quarter (QoQ) sales up 3%.” As Hifyre IQ reported, even though 13% YoY growth "is better than the flat trends we are seeing in the US

The Valens Company Inc. (NASDAQ:VLNS) (TSX:VLNS) announced the mailing of its management information circular and related documents for the special meeting of valens shareholders in connection with the previously announced plan of arrangement under section 192 of the Canada Business Corporations Act whereby SNDL Inc. (NASDAQ:SNDL) will acquire all of the issued and outstanding common shares of the company, and in return Valens shareholders will receive, for each Valens share held, 0.3334 common shares of SNDL. The SNDL shares to be issued to Valens shareholders represents an implied value of $1.26 per Valens share, based on the August 19, 2022 close of the SNDL shares on the Nasdaq Capital

6-K - Valens Company, Inc. (0001859902) (Filer)

Valens Shareholders will receive 0.3334 SNDL shares per Valens share, representing a premium of approximately 48% on the 10-day VWAP of the Valens shares on the TSX prior to the signing of a non-binding expression of interest related to the transaction Shareholders are encouraged to vote well in advance of the proxy deadline of November 25, 2022 at 10:00 a.m. (Toronto time) Shareholders who have questions or need assistance in voting should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 (North American Toll Free) or 1-416- 304-0211 (Outside North America), or by email at assistance@laurelhill.com KELOWNA, BC, Oct. 27, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS)

6-K - Valens Company, Inc. (0001859902) (Filer)